Literature DB >> 31069617

Emerging Role of SOX Proteins in Breast Cancer Development and Maintenance.

Gaurav A Mehta1,2,3, Pooja Khanna1,2,3, Michael L Gatza4,5,6.   

Abstract

The SOX genes encode a family of more than 20 transcription factors that are critical regulators of embryogenesis and developmental processes and, when aberrantly expressed, have been shown to contribute to tumor development and progression in both an oncogenic and tumor suppressive role. Increasing evidence demonstrates that the SOX proteins play essential roles in multiple cellular processes that mediate or contribute to oncogenic transformation and tumor progression. In the context of breast cancer, SOX proteins function both as oncogenes and tumor suppressors and have been shown to be associated with tumor stage and grade and poor prognosis. Experimental evidence demonstrates that a subset of SOX proteins regulate critical aspects of breast cancer biology including cancer stemness and multiple signaling pathways leading to altered cell proliferation, survival, and tumor development; EMT, cell migration and metastasis; as well as other tumor associated characteristics. This review will summarize the role of SOX family members as important mediators of tumorigenesis in breast cancer, with an emphasis on the triple negative or basal-like subtype of breast cancer, as well as examine the therapeutic potential of these genes and their downstream targets.

Entities:  

Keywords:  Breast cancer; Cancer stem cells; EMT; Oncogene; Signaling; Sox

Mesh:

Substances:

Year:  2019        PMID: 31069617      PMCID: PMC6790170          DOI: 10.1007/s10911-019-09430-6

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  176 in total

1.  Utility of Sox10 labeling in metastatic breast carcinomas.

Authors:  Emily R Nelson; Rajni Sharma; Pedram Argani; Ashley Cimino-Mathews
Journal:  Hum Pathol       Date:  2017-08-23       Impact factor: 3.466

2.  Sox4 stimulates ß-catenin activity through induction of CK2.

Authors:  Ae-Kyung Lee; Sang-Gun Ahn; Jung-Hoon Yoon; Soo-A Kim
Journal:  Oncol Rep       Date:  2010-12-09       Impact factor: 3.906

3.  Identification of upstream transcription factors (TFs) for expression signature genes in breast cancer.

Authors:  Hongyan Zang; Ning Li; Yuling Pan; Jingguang Hao
Journal:  Gynecol Endocrinol       Date:  2016-11-04       Impact factor: 2.260

4.  Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.

Authors:  Muyi Yang; Jing Wang; Lin Wang; Chengwu Shen; Bo Su; Mei Qi; Jing Hu; Wei Gao; Weiwei Tan; Bo Han
Journal:  Prostate       Date:  2015-05-27       Impact factor: 4.104

5.  Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice.

Authors:  Hanseul Yang; Sungsu Lee; Seungjoo Lee; Kangsan Kim; Yeseul Yang; Jeong Hoon Kim; Ralf H Adams; James M Wells; Sean J Morrison; Gou Young Koh; Injune Kim
Journal:  J Clin Invest       Date:  2012-12-17       Impact factor: 14.808

Review 6.  Sox genes and cancer.

Authors:  C Dong; D Wilhelm; P Koopman
Journal:  Cytogenet Genome Res       Date:  2004       Impact factor: 1.636

7.  Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.

Authors:  Katherine A Hoadley; Christina Yau; Denise M Wolf; Andrew D Cherniack; David Tamborero; Sam Ng; Max D M Leiserson; Beifang Niu; Michael D McLellan; Vladislav Uzunangelov; Jiashan Zhang; Cyriac Kandoth; Rehan Akbani; Hui Shen; Larsson Omberg; Andy Chu; Adam A Margolin; Laura J Van't Veer; Nuria Lopez-Bigas; Peter W Laird; Benjamin J Raphael; Li Ding; A Gordon Robertson; Lauren A Byers; Gordon B Mills; John N Weinstein; Carter Van Waes; Zhong Chen; Eric A Collisson; Christopher C Benz; Charles M Perou; Joshua M Stuart
Journal:  Cell       Date:  2014-08-07       Impact factor: 41.582

8.  Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer.

Authors:  Socorro M Rodriguez-Pinilla; David Sarrio; Gema Moreno-Bueno; Yolanda Rodriguez-Gil; Miguel A Martinez; Lucia Hernandez; David Hardisson; Jorge S Reis-Filho; Jose Palacios
Journal:  Mod Pathol       Date:  2007-03-02       Impact factor: 7.842

9.  MicroRNA-320 inhibits cell proliferation and invasion in breast cancer cells by targeting SOX4.

Authors:  Jun-Wen Bai; Xia Wang; Ya-Feng Zhang; Guo-Dong Yao; Hong Liu
Journal:  Oncol Lett       Date:  2017-09-27       Impact factor: 2.967

10.  SOX5 induces lung adenocarcinoma angiogenesis by inducing the expression of VEGF through STAT3 signaling.

Authors:  Xin Chen; Qi Zheng; Weidong Li; Yuan Lu; Yiming Ni; Liang Ma; Yufei Fu
Journal:  Onco Targets Ther       Date:  2018-09-11       Impact factor: 4.147

View more
  5 in total

1.  Methodology to analyze gene expression patterns of early mammary development in pig models.

Authors:  Matthew A Moss; Breanne Williams; Farzana Ferdous; Tom Scott; Heather W Dunn
Journal:  Mol Biol Rep       Date:  2020-03-26       Impact factor: 2.316

2.  SOX11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells.

Authors:  Erik Oliemuller; Richard Newman; Siu Man Tsang; Shane Foo; Gareth Muirhead; Farzana Noor; Syed Haider; Iskander Aurrekoetxea-Rodríguez; Maria dM Vivanco; Beatrice A Howard
Journal:  Elife       Date:  2020-09-10       Impact factor: 8.140

3.  SOX4 and SMARCA4 cooperatively regulate PI3k signaling through transcriptional activation of TGFBR2.

Authors:  Gaurav A Mehta; Steven P Angus; Christen A Khella; Kevin Tong; Pooja Khanna; Shelley A H Dixon; Michael P Verzi; Gary L Johnson; Michael L Gatza
Journal:  NPJ Breast Cancer       Date:  2021-04-09

Review 4.  Editing SOX Genes by CRISPR-Cas: Current Insights and Future Perspectives.

Authors:  Ali Dehshahri; Alessio Biagioni; Hadi Bayat; E Hui Clarissa Lee; Mohammad Hashemabadi; Hojjat Samareh Fekri; Ali Zarrabi; Reza Mohammadinejad; Alan Prem Kumar
Journal:  Int J Mol Sci       Date:  2021-10-20       Impact factor: 5.923

5.  Chromatin accessibility landscape and active transcription factors in primary human invasive lobular and ductal breast carcinomas.

Authors:  Sanghoon Lee; Hatice Ulku Osmanbeyoglu
Journal:  Breast Cancer Res       Date:  2022-07-29       Impact factor: 8.408

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.